Characteristics of new HIV diagnoses over 1995-2019: A clinic-based study in Montréal, Canada. by Katia Giguère, Maliheh Vaziri, Clément Olivier, Louise Charest, Jason Szabo, Réjean Thomas, Mathieu Maheu-Giroux

Get full text

Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort. by Réjean Thomas, Chrissi Galanakis, Sylvie Vézina, Danièle Longpré, Michel Boissonnault, Emmanuelle Huchet, Louise Charest, Daniel Murphy, Benoît Trottier, Nimâ Machouf

Get full text

High seroconversion rates following PrEP discontinuance in a Montreal clinic by Zoë Greenwald, Mariève Beauchemin, Khadija Benomar, Gabrielle Landry, Alexandra Hamel, Michel Boissonnault, Louise Charest, Danièle Longpré, Stéphane Lavoie, Réjean Thomas

Get full text

Two-years persistence of anal high-risk HPV infections in women living with HIV, results from the EVVA study by Alexandra de Pokomandy, Alexandra de Pokomandy, Bernard Lessard, Marie-Hélène Mayrand, Louise Charest, Victoria Marcus, Ann Burchell, Sophie Rodrigues-Coutlée, François Coutlée

Get full text

Identifying risk factors for prevalent anal human papillomavirus type 16 infection in women living with HIV. by Elaina Kaufman, Tyler Williamson, Marie-Hélène Mayrand, Ann N Burchell, Marina Klein, Louise Charest, Sophie Rodrigues-Coutlée, François Coutlée, Alexandra de Pokomandy, EVVA study group

Get full text